RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
-13.4%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$4.83B
AUM Growth
+$4.83B
(-29%)
Cap. Flow
-$900M
Cap. Flow
% of AUM
-18.64%
Top 10 Holdings %
Top 10 Hldgs %
38.68%
Holding
126
New
2
Increased
20
Reduced
30
Closed
20
Top Buys
| 1 |
Protagonist Therapeutics
PTGX
|
$52M |
| 2 |
C4 Therapeutics
CCCC
|
$49.4M |
| 3 |
Masimo
MASI
|
$40.4M |
| 4 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$24.4M |
| 5 |
TSVT
2seventy bio
TSVT
|
$21M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$423M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$112M |
| 3 |
Apellis Pharmaceuticals
APLS
|
$98.5M |
| 4 |
iTeos Therapeutics
ITOS
|
$60M |
| 5 |
IDEAYA Biosciences
IDYA
|
$59.6M |
Sector Composition
| 1 | Healthcare | 99.3% |
| 2 | Financials | 0.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Stoke Therapeutics
STOK
$1.08B
| $76.7M | 1.59% | 3,644,248 | – | – |
|
27
Relmada Therapeutics
RLMD
$37.2M
| $68.6M | 1.42% | 2,540,074 +353,750 | +16% | +$9.55M |
|
28
Axsome Therapeutics
AXSM
$6.05B
| $67M | 1.39% | 1,618,819 | – | – |
|
29
Regenxbio
RGNX
$451M
| $61.2M | 1.27% | 1,845,366 | – | – |
|
30
Adicet Bio
ACET
$59.9M
| $59.7M | 1.24% | 2,989,482 -34,262 | -1% | -$684K |
|
|
BCYC
31
Bicycle Therapeutics
BCYC
$511M
| $56M | 1.16% | 1,276,276 +407,005 | +47% | +$17.9M |
|
32
10x Genomics
TXG
$1.74B
| $55.9M | 1.16% | 734,481 | – | – |
|
33
Immunocore
IMCR
$1.62B
| $55.6M | 1.15% | 1,859,471 +613,939 | +49% | +$18.4M |
|
|
DMTK
34
DELISTED
DermTech, Inc. Common Stock
DMTK
| $45.8M | 0.95% | 3,118,666 | – | – |
|
35
Guardant Health
GH
$8.41B
| $45.7M | 0.95% | 689,887 -123,455 | -15% | -$8.18M |
|
36
Outset Medical
OM
$247M
| $40.8M | 0.85% | 899,652 +5,000 | +0.6% | +$227K |
|
37
GH Research
GHRS
$837M
| $39.7M | 0.82% | 2,168,957 | – | – |
|
|
AVDL
38
Avadel Pharmaceuticals
AVDL
$1.43B
| $39.2M | 0.81% | 5,741,939 | – | – |
|
39
Quanterix
QTRX
$211M
| $36.4M | 0.75% | 1,248,517 +562,047 | +82% | +$16.4M |
|
40
MacroGenics
MGNX
$112M
| $35M | 0.72% | 3,975,554 | – | – |
|
41
Tarsus Pharmaceuticals
TARS
$2.47B
| $33.9M | 0.7% | 2,013,601 | – | – |
|
|
JNCE
42
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $31.8M | 0.66% | 4,680,412 +1,817,214 | +63% | +$12.3M |
|
43
Immunic
IMUX
$80.9M
| $30.6M | 0.63% | 2,705,513 +990,043 | +58% | +$11.2M |
|
44
Tenaya Therapeutics
TNYA
$184M
| $29M | 0.6% | 2,458,750 | – | – |
|
45
Milestone Pharmaceuticals
MIST
$156M
| $27.7M | 0.57% | 4,315,102 | – | – |
|
46
Athira Pharma
ATHA
$15.3M
| $25.7M | 0.53% | 1,906,557 | – | – |
|
|
CINC
47
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $24.4M | 0.5% | +1,389,705 | New | +$24.4M |
|
|
OYST
48
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $24M | 0.5% | 2,058,504 | – | – |
|
49
Castle Biosciences
CSTL
$696M
| $22.3M | 0.46% | 496,675 -102,334 | -17% | -$4.59M |
|
50
Apyx Medical
APYX
$75.3M
| $22.2M | 0.46% | 3,398,279 | – | – |
|